CN110114067A - 3-羟基丁酸甘油酯用于创伤性脑损伤 - Google Patents
3-羟基丁酸甘油酯用于创伤性脑损伤 Download PDFInfo
- Publication number
- CN110114067A CN110114067A CN201780080457.XA CN201780080457A CN110114067A CN 110114067 A CN110114067 A CN 110114067A CN 201780080457 A CN201780080457 A CN 201780080457A CN 110114067 A CN110114067 A CN 110114067A
- Authority
- CN
- China
- Prior art keywords
- hydroxybutyrate
- glyceride
- tbi
- administration
- fatty acyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/404,396 | 2017-01-12 | ||
| US15/404,396 US9925164B1 (en) | 2017-01-12 | 2017-01-12 | Glyceryl 3-hydroxybutyrates for traumatic brain injury |
| PCT/US2017/063853 WO2018132189A1 (en) | 2017-01-12 | 2017-11-30 | Glyceryl 3-hydroxybutyrates for traumatic brain injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110114067A true CN110114067A (zh) | 2019-08-09 |
Family
ID=61633011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780080457.XA Pending CN110114067A (zh) | 2017-01-12 | 2017-11-30 | 3-羟基丁酸甘油酯用于创伤性脑损伤 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9925164B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3568129A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7278593B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102443942B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110114067A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019014128A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3046355C (cg-RX-API-DMAC7.html) |
| IL (1) | IL267934B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX391851B (cg-RX-API-DMAC7.html) |
| MY (1) | MY207193A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018132189A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116113617A (zh) * | 2020-07-13 | 2023-05-12 | Ioi油脂化学品有限责任公司 | 氧代丁醇酯化的多元羧酸聚甘油酯的制备方法 |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11241403B2 (en) | 2016-03-11 | 2022-02-08 | Axcess Global Sciences, Llc | Beta-hydroxybutyrate mixed salt compositions and methods of use |
| US11103470B2 (en) | 2017-11-22 | 2021-08-31 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US12109182B2 (en) | 2016-04-19 | 2024-10-08 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US12521378B2 (en) | 2016-04-19 | 2026-01-13 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans |
| US12533346B2 (en) | 2016-04-19 | 2026-01-27 | Axcess Global Sciences, Llc | Administration of berberine metabolites |
| US11806324B2 (en) | 2018-04-18 | 2023-11-07 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies |
| US12329734B2 (en) | 2017-12-19 | 2025-06-17 | Axcess Global Sciences, Llc | Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow |
| US10925843B2 (en) | 2018-04-18 | 2021-02-23 | Axcess Global Sciences, Llc | Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate |
| US20230346721A1 (en) | 2018-04-18 | 2023-11-02 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies |
| US11202769B2 (en) | 2017-11-22 | 2021-12-21 | Axcess Global Sciences, Llc | Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function |
| US11944598B2 (en) | 2017-12-19 | 2024-04-02 | Axcess Global Sciences, Llc | Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer |
| US12599579B2 (en) | 2016-04-19 | 2026-04-14 | Axcess Global Sciences, Llc | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids |
| SG11201809211QA (en) * | 2016-04-19 | 2018-11-29 | Keto Patent Group Inc | Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans |
| US11026929B2 (en) | 2016-04-19 | 2021-06-08 | Keto Patent Group, Inc. | Administration of berberine metabolites |
| US12496283B2 (en) | 2016-04-19 | 2025-12-16 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US12622889B2 (en) | 2016-04-19 | 2026-05-12 | Axcess Global Sciences, Llc | S-β-hydroxybutyrate esters for improving metabolic function |
| US10376528B2 (en) | 2017-03-10 | 2019-08-13 | Tecton Group, Llc | Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor |
| US12171735B2 (en) | 2017-04-19 | 2024-12-24 | Axcess Global Sciences, Llc | Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans |
| GB201715654D0 (en) | 2017-09-27 | 2017-11-08 | Tdeltas Ltd | Method of treatment |
| US12090129B2 (en) | 2017-11-22 | 2024-09-17 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| WO2020147978A1 (de) * | 2019-01-17 | 2020-07-23 | Ioi Oleo Gmbh | Verfahren zur herstellung von glyceriden von hydroxycarbonsäuren |
| ES2965646T3 (es) * | 2019-01-17 | 2024-04-16 | Ketolipix Therapeutics Gmbh | Procedimiento para la producción de lípidos que contienen unidades estructurales a base de glicéridos de ácidos hidroxicarboxílicos |
| US12472200B2 (en) | 2019-05-15 | 2025-11-18 | Axcess Global Sciences, Llc | Autobiotic compositions and method for promoting healthy gut microbiome |
| CN113710243A (zh) * | 2019-05-30 | 2021-11-26 | 神经活力投资公司 | 甘油三(β-羟基丁酸酯)与神经元短暂性脑缺血发作 |
| ES2969217T3 (es) * | 2019-06-12 | 2024-05-17 | Ketolipix Therapeutics Gmbh | Procedimiento para la producción de ésteres a base de poliol, en particular ésteres de poliglicerol, de ácidos hidroxicarboxílicos |
| CN113966323B (zh) * | 2019-06-12 | 2023-11-28 | 凯托利皮克斯治疗有限责任公司 | 一种用于生产酮羧酸多元醇基酯的方法 |
| US12167993B2 (en) | 2019-06-21 | 2024-12-17 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US11969430B1 (en) | 2023-03-10 | 2024-04-30 | Axcess Global Sciences, Llc | Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance |
| US11950616B2 (en) | 2019-06-21 | 2024-04-09 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US12186297B2 (en) | 2020-08-26 | 2025-01-07 | Axcess Global Sciences, Llc | Compositions and methods for increasing lean-to-fat mass ratio |
| WO2023283654A1 (en) * | 2021-07-09 | 2023-01-12 | Georgia State University Research Foundation, Inc. | The use of beta-hydroxybutyrates for the treatment or prevention of aneurysms and dissections |
| AU2022387742A1 (en) | 2021-11-12 | 2024-06-27 | Arxada Ag | Polyol-derived compounds |
| WO2023094654A1 (en) | 2021-11-26 | 2023-06-01 | Arxada Ag | Acetoacetate based ketals |
| US12023382B2 (en) | 2022-01-18 | 2024-07-02 | Today Inc. | Molecules, formulations, and methods for nutritional support of athletes, patients, and others |
| WO2023139357A1 (en) * | 2022-01-18 | 2023-07-27 | Today Inc. | Molecules, nutritional formulations, and methods of providing nutritional support |
| US20230277484A1 (en) * | 2022-03-04 | 2023-09-07 | Guardian Biosciences, LLC | Compositions and methods to promote brain health |
| EP4605371A1 (en) | 2022-10-18 | 2025-08-27 | Arxada AG | Polyol-derived compounds |
| WO2025074001A2 (en) | 2023-10-05 | 2025-04-10 | Arxada Ag | Enzymatic reduction of acetoacetate |
| WO2025196156A1 (en) | 2024-03-20 | 2025-09-25 | Arxada Ag | Continuous hydrogenation process of acetoacetate esters |
| WO2025224319A1 (en) | 2024-04-25 | 2025-10-30 | Arxada Ag | Reduction of acetoacetate esters in the presence of amines |
| WO2026090272A1 (en) * | 2024-10-23 | 2026-04-30 | 2508 Biosciences Llc | Methods and compositions for the treatment of disease |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008005818A1 (en) * | 2006-06-30 | 2008-01-10 | Stepan Co | Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose |
| WO2011101171A1 (en) * | 2010-02-22 | 2011-08-25 | Tdeltas Limited | Nutritional composition |
| WO2015034812A2 (en) * | 2013-09-04 | 2015-03-12 | Beth Israel Deaconess Medical Center | A new ketogenic diet and its use in treating the critically ill |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4598203B2 (ja) | 1995-12-01 | 2010-12-15 | ビーティージー・インターナショナル・リミテッド | 脳機能改善剤 |
| US6323237B1 (en) | 1997-03-17 | 2001-11-27 | Btg International Limited | Therapeutic compositions |
| CN1315473C (zh) * | 1997-03-17 | 2007-05-16 | 英国技术集团国际有限公司 | 治疗组合物 |
| US8124589B2 (en) | 2000-05-01 | 2012-02-28 | Accera, Inc. | Use of ketogenic compounds for treatment of age-associated memory impairment |
| GB0420856D0 (en) * | 2004-09-20 | 2004-10-20 | Ketocytonyx Inc | Cns modulators |
| CN103505728A (zh) | 2005-05-26 | 2014-01-15 | 科罗拉多大学评议会法人机构 | 用于治疗外伤性脑损伤、脊髓损伤及相关病症的补体旁路抑制 |
| CA2684213A1 (en) | 2007-04-12 | 2008-10-23 | Regents Of The University Of Minnesota | Ischemia/reperfusion protection compositions and methods of using |
| JP2009173766A (ja) | 2008-01-24 | 2009-08-06 | Ono Kogei Kk | 炭素繊維含有コーティング組成物およびその調製方法 |
| US8642654B2 (en) | 2009-04-16 | 2014-02-04 | Isis Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| AU2010207597A1 (en) | 2009-01-24 | 2011-08-18 | Phytopharm Plc | Treatment of neurotrophic factor mediated disorders |
| CA2873057C (en) | 2011-05-09 | 2020-02-25 | University Of South Florida | The use of ketone esters for prevention of cns oxygen toxicity |
| US20140072654A1 (en) | 2011-12-23 | 2014-03-13 | Savind, Inc. | Cancer with metabolic therapy and hyperbaric oxygen |
| FR2997302B1 (fr) | 2012-10-29 | 2015-02-06 | Assist Publ Hopitaux De Paris | Prevention et traitement des deficits en pyruvate deshydrogenase |
| WO2014071389A1 (en) | 2012-11-05 | 2014-05-08 | Veech Richard L | Ketone bodies to protect tissues from damage by ionizing radiation |
| EP2925308B1 (en) | 2012-11-28 | 2019-12-25 | University Of South Florida | Targeting cancer with metabolic therapy and hyperbaric oxygen |
| BR112015024186B1 (pt) | 2013-03-19 | 2023-05-09 | University Of South Florida | Composições e métodos para produção de cetose de elevação e manutenção |
| CA2973342A1 (en) | 2014-01-13 | 2015-10-15 | University Of South Florida | Methods of sustaining dietary ketosis and its effects on lipid profile |
| US20160078782A1 (en) | 2014-09-17 | 2016-03-17 | The Trustees Of Boston College | Glucose Ketone Index for MetabolicTherapy |
| US9364456B1 (en) | 2015-06-30 | 2016-06-14 | University Of South Florida | Ketone esters for treatment of angelman syndrome |
| US20180200220A1 (en) | 2015-07-10 | 2018-07-19 | Cognate Nutritionals, Inc. | Prophylaxis and mitigation of migraine headaches using ketogenic medium chain triglycerides, ketone esters, and other ketogenic sources |
| US10292952B2 (en) | 2016-03-11 | 2019-05-21 | Axcess Global Sciences, Llc | Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis |
| US20190091189A1 (en) | 2016-03-21 | 2019-03-28 | Csilla Ari D'Agostino | Administration of exogenous ketone to lower blood glucose |
| US10376482B2 (en) | 2016-04-03 | 2019-08-13 | Franco Cavaleri | Butyrate and beta-hydroxybutyrate compositions |
| SG11201809211QA (en) | 2016-04-19 | 2018-11-29 | Keto Patent Group Inc | Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans |
| WO2018009208A1 (en) | 2016-07-08 | 2018-01-11 | Cognate Nutritionals, Inc. | Nutritional mitiggation of the cns effects of traumatic brain injury |
| US10588877B2 (en) | 2016-07-21 | 2020-03-17 | Savind, Inc. | Compositions comprising β-hydroxybutyric acid and salt, and methods of using the same |
| US20180057846A1 (en) | 2016-08-30 | 2018-03-01 | KetoneAid Inc. | Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy |
| US20180055797A1 (en) | 2016-08-31 | 2018-03-01 | KetoneAid Inc. | Non-racemic ketone salts for rapid-onset nutritional ketosis and metabolic therapy |
| JP2019526607A (ja) | 2016-09-12 | 2019-09-19 | ユニバーシティ・オブ・サウス・フロリダ | ケトンにより改善された神経再生 |
-
2017
- 2017-01-12 US US15/404,396 patent/US9925164B1/en active Active
- 2017-11-30 MY MYPI2019003665A patent/MY207193A/en unknown
- 2017-11-30 CN CN201780080457.XA patent/CN110114067A/zh active Pending
- 2017-11-30 BR BR112019014128-6A patent/BR112019014128A2/pt not_active Application Discontinuation
- 2017-11-30 EP EP17891194.7A patent/EP3568129A4/en active Pending
- 2017-11-30 JP JP2019536598A patent/JP7278593B2/ja active Active
- 2017-11-30 CA CA3046355A patent/CA3046355C/en active Active
- 2017-11-30 WO PCT/US2017/063853 patent/WO2018132189A1/en not_active Ceased
- 2017-11-30 KR KR1020197020924A patent/KR102443942B1/ko active Active
- 2017-11-30 MX MX2019008269A patent/MX391851B/es unknown
- 2017-11-30 IL IL267934A patent/IL267934B2/en unknown
-
2018
- 2018-03-01 US US15/909,240 patent/US10736867B2/en active Active
-
2020
- 2020-06-10 US US16/897,349 patent/US11638702B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008005818A1 (en) * | 2006-06-30 | 2008-01-10 | Stepan Co | Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose |
| WO2011101171A1 (en) * | 2010-02-22 | 2011-08-25 | Tdeltas Limited | Nutritional composition |
| WO2015034812A2 (en) * | 2013-09-04 | 2015-03-12 | Beth Israel Deaconess Medical Center | A new ketogenic diet and its use in treating the critically ill |
Non-Patent Citations (6)
| Title |
|---|
| HAYDEN WHITE等: "Clinical review: Ketones and brain injury", 《CRITICAL CARE》 * |
| INSTITUTE OF MEDICINE COMMITTEE ON NUTRITION TRAUMA AND THE BRAI: "《Nutrition and Traumatic Brain Injury》", 30 November 2011 * |
| MACIEJ GASIORA等: "Neuroprotective and disease-modifying effects of the ketogenic diet", 《BEHAV PHARMACLO.》 * |
| MAYUMI L. PRINS等: "The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury", 《JOURNAL OF LIPID RESEARCH》 * |
| SAMI A. HASHIM等: "Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester", 《JOURNAL OF LIPID RESEARCH》 * |
| YANG SHUGUANG等: "Arachidonic acid: a bridge between traumatic brain injury and fracture healing", 《JOURNAL OF NEUROTRAUMA》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116113617A (zh) * | 2020-07-13 | 2023-05-12 | Ioi油脂化学品有限责任公司 | 氧代丁醇酯化的多元羧酸聚甘油酯的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| IL267934B1 (en) | 2024-05-01 |
| MY207193A (en) | 2025-02-05 |
| KR20190104546A (ko) | 2019-09-10 |
| JP7278593B2 (ja) | 2023-05-22 |
| JP2020504134A (ja) | 2020-02-06 |
| US9925164B1 (en) | 2018-03-27 |
| US11638702B2 (en) | 2023-05-02 |
| MX2019008269A (es) | 2019-09-13 |
| US10736867B2 (en) | 2020-08-11 |
| CA3046355C (en) | 2023-08-01 |
| IL267934B2 (en) | 2024-09-01 |
| KR102443942B1 (ko) | 2022-09-15 |
| IL267934A (en) | 2019-09-26 |
| WO2018132189A1 (en) | 2018-07-19 |
| EP3568129A4 (en) | 2020-12-09 |
| US20180193300A1 (en) | 2018-07-12 |
| CA3046355A1 (en) | 2018-07-19 |
| US20200297686A1 (en) | 2020-09-24 |
| MX391851B (es) | 2025-03-21 |
| BR112019014128A2 (pt) | 2020-06-16 |
| EP3568129A1 (en) | 2019-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11638702B2 (en) | Glyceryl 3-hydroxybutyrates for traumatic brain injury | |
| Antushevich | Fecal microbiota transplantation in disease therapy | |
| JP7108320B2 (ja) | 片頭痛の症状を管理するためのグリセリル3-ヒドロキシブチラート | |
| JP2020504134A5 (cg-RX-API-DMAC7.html) | ||
| Hooper et al. | Controversies and misconceptions in intensive care unit nutrition | |
| Quintard et al. | Nutritional and metabolic supplementation for the injured brain: an update | |
| RS20050226A (sr) | EIKOSAPENTAENOIČNA KISELINA (EPA) ZA LEČENjE ANOREXIA NERVOSA I BULIMIJE | |
| JP7847432B2 (ja) | 食後血糖応答を制御するための乳清タンパク質ミセルの使用 | |
| Lane et al. | Ketogenic diet and health | |
| Griffiths | Specialized nutrition support in critically ill patients | |
| Phillips | Ketogenic diet therapies in children and adults with epilepsy | |
| Kuźniar et al. | Ketogenic diet and intermittent fasting-impact on body weight and various diseases | |
| HK40012461A (en) | Glyceryl 3-hydroxybutyrates for traumatic brain injury | |
| CN109999044B (zh) | 一种含有醉茄素a的组合物及其应用 | |
| JPWO2013005834A1 (ja) | 高純度epaを含有する抗肥満剤 | |
| CN109908165B (zh) | 一种含有雷公藤红素的组合物及其应用 | |
| JP2011241216A (ja) | モズク由来のフコイダンを含む食品 | |
| Hu et al. | Impact of zinc supplementation on the clinical outcomes in critically ill patients: A systematic review and meta-analysis | |
| Górska et al. | Apple Cider Vinegar in the Combat Against Type 2 Diabetes and Obesity–An Overview of Recent Research | |
| Wei et al. | Mucosal Immunity and Autoimmune Diseases: New Perspectives From Mechanisms to Treatment | |
| Di Lorenzo et al. | Position Paper on the Applications of Ketogenic Diets in Patients with Headache: Consensus Statement | |
| Enns et al. | Clinical outcomes of major clinical events and emergency triheptanoin use in critically ill patients with long-chain fatty acid oxidation disorders | |
| WO2022115293A1 (en) | Parenteral nutrition formulation comprising arginine butyrate | |
| Egleston | Common toxins in dogs | |
| grief will become a Major | MENTAL DISORDERS FOR EVERYONE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40012461 Country of ref document: HK |